Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greene Holcomb Fisher (GH&F) was a leading middle-market investment banking firm that provided merger and acquisition advisory, private placements, and financial advisory services. While not a biotechnology company itself, the firm maintained a robust Healthcare and Life Sciences practice, advising companies in medical technology, healthcare services, and biopharmaceutical sectors. Headquartered in Minneapolis, the firm was known for its deep industry expertise and high-touch advisory model for growth-oriented companies. In 2016, Greene Holcomb Fisher was acquired by BMO Capital Markets to bolster BMO's M&A presence in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greene Holcomb & Fisher.